No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Heilongjiang ZBD Pharmaceutical Secures Approval for Chemical Raw Material Drug Listing
ZBD Pharma Gets China Approval for Antibacterial Injection
Report for the third quarter of 2024 of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
China Rejects ZBD Pharmaceutical's Application For Skin Infection Drug
Heilongjiang ZBD Pharmaceutical Co., Ltd. 2024 Semi-annual Report
Heilongjiang ZBD Pharmaceutical Co., Ltd. 2024 Interim Report Summary
No Data